Localized junctional epidermolysis bullosa Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

1 event

Dec 2022

NexoBrid: FDA approved

eschar removal in adults with deep partial thickness (DPT) and/or full thickness (FT) thermal burns

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

NexoBrid

Vericel Corporation

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

NexoBrid

(anacaulase-bcdb)Orphan drug

Vericel Corporation

12.1 Mechanism of Action The mixture of enzymes in NEXOBRID dissolves burn wound eschar. The specific components responsible for this effect have not ...

Approved Dec 2022FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Localized junctional epidermolysis bullosa.
Search all trials →

Search clinical trials for Localized junctional epidermolysis bullosa →

Recent News & Research

No recent news articles indexed yet for Localized junctional epidermolysis bullosa.
Search PubMed for Localized junctional epidermolysis bullosa →

Browse all Localized junctional epidermolysis bullosa news →

Specialist Network

No specialists currently listed for Localized junctional epidermolysis bullosa.

View all Localized junctional epidermolysis bullosa specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰